FluGen[Affiliation] - Search Results

Year	Number of Results
2014	1
2016	1
2017	1
2018	1
2019	1
2020	2
2021	2
2022	3
2023	2
2024	3
2025	1
2026	0

1

Mucosal immunization with dual influenza/COVID-19 single-replication virus vector protects hamsters from SARS-CoV-2 challenge.

Hill-Batorski L, Bowen R, Bielefeldt-Ohmann H, Moser MJ, Matejka SM, Marshall D, Kawaoka Y, Neumann G, Bilsel P. Hill-Batorski L, et al. Vaccine. 2024 Apr 19;42(11):2770-2780. doi: 10.1016/j.vaccine.2024.03.040. Epub 2024 Mar 20. Vaccine. 2024. PMID: 38508930

2

Monocyte apoptotic bodies are vehicles for influenza A virus propagation.

Atkin-Smith GK, Duan M, Zanker DJ, Loh L, Nguyen THO, Koutsakos M, Nguyen T, Jiang X, Carrera J, Phan TK, Liu C, Paone S, Oveissi S, Hodge AL, Baxter AA, Kedzierska K, Mackenzie JM, Hulett MD, Bilsel P, Chen W, Poon IKH. Atkin-Smith GK, et al. Commun Biol. 2020 May 8;3(1):223. doi: 10.1038/s42003-020-0955-8. Commun Biol. 2020. PMID: 32385344 Free PMC article.

3

Intranasal M2SR and BM2SR Vaccine Viruses Do Not Shed or Transmit in Ferrets.

Hatta Y, Hill-Batorski L, Moser MJ, Marshall D, Boltz DA, Westfall L, Herber R, Sarawar S, Bilsel P. Hatta Y, et al. Vaccines (Basel). 2024 Oct 29;12(11):1228. doi: 10.3390/vaccines12111228. Vaccines (Basel). 2024. PMID: 39591131 Free PMC article.

4

Intranasal Single-Replication Influenza Vector Induces Cross-Reactive Serum and Mucosal Antibodies against SARS-CoV-2 Variants.

Moser MJ, Hill-Batorski L, Bowen RA, Matejka SM, Marshall D, Kawaoka Y, Neumann G, Bilsel P. Moser MJ, et al. Vaccines (Basel). 2023 Jun 5;11(6):1063. doi: 10.3390/vaccines11061063. Vaccines (Basel). 2023. PMID: 37376452 Free PMC article.

5

Intranasal M2SR (M2-Deficient Single Replication) H3N2 Influenza Vaccine Provides Enhanced Mucosal and Serum Antibodies in Adults.

Eiden J, Fierro C, Schwartz H, Adams M, Ellis KJ, Aitchison R, Herber R, Hatta Y, Marshall D, Moser MJ, Belshe R, Greenberg H, Coelingh K, Kawaoka Y, Neumann G, Bilsel P. Eiden J, et al. J Infect Dis. 2022 Dec 28;227(1):103-112. doi: 10.1093/infdis/jiac433. J Infect Dis. 2022. PMID: 36350017 Free PMC article. Clinical Trial.

6

Safety and immunogenicity of the intranasal H3N2 M2-deficient single-replication influenza vaccine alone or coadministered with an inactivated influenza vaccine (Fluzone High-Dose Quadrivalent) in adults aged 65-85 years in the USA: a multicentre, randomised, double-blind, double-dummy, phase 1b trial.

Eiden J, Fierro C, White A, Davis M, Rhee M, Turner M, Murray B, Herber R, Aitchison R, Marshall D, Moser MJ, Belshe R, Greenberg H, Coelingh K, Kawaoka Y, Neumann G, Bilsel P. Eiden J, et al. Lancet Infect Dis. 2024 Oct;24(10):1118-1129. doi: 10.1016/S1473-3099(24)00351-7. Epub 2024 Jul 11. Lancet Infect Dis. 2024. PMID: 39004096 Clinical Trial.

7

M2-Deficient Single-Replication Influenza Vaccine-Induced Immune Responses Associated With Protection Against Human Challenge With Highly Drifted H3N2 Influenza Strain.

Eiden J, Volckaert B, Rudenko O, Aitchison R, Herber R, Belshe R, Greenberg H, Coelingh K, Marshall D, Kawaoka Y, Neumann G, Bilsel P. Eiden J, et al. J Infect Dis. 2022 Aug 12;226(1):83-90. doi: 10.1093/infdis/jiab374. J Infect Dis. 2022. PMID: 34323977 Free PMC article.

8

Influenza A virus infection-induced macroautophagy facilitates MHC class II-restricted endogenous presentation of an immunodominant viral epitope.

Deng J, Lu C, Liu C, Oveissi S, Fairlie WD, Lee EF, Bilsel P, Puthalakath H, Chen W. Deng J, et al. FEBS J. 2021 May;288(10):3164-3185. doi: 10.1111/febs.15654. Epub 2020 Dec 18. FEBS J. 2021. PMID: 33830641 Free article.

9

Quadrivalent Formulation of Intranasal Influenza Vaccine M2SR (M2-Deficient Single Replication) Protects against Drifted Influenza A and B Virus Challenge.

Hill-Batorski L, Hatta Y, Moser MJ, Sarawar S, Neumann G, Kawaoka Y, Bilsel P. Hill-Batorski L, et al. Vaccines (Basel). 2023 Apr 4;11(4):798. doi: 10.3390/vaccines11040798. Vaccines (Basel). 2023. PMID: 37112710 Free PMC article.

10

Safety and Immunogenicity of M2-Deficient, Single Replication, Live Influenza Vaccine (M2SR) in Adults.

Eiden J, Gordon G, Fierro C, Herber R, Aitchison R, Belshe R, Greenberg H, Hoft D, Hatta Y, Moser MJ, Tary-Lehmann M, Kawaoka Y, Neumann G, Radspinner P, Bilsel P. Eiden J, et al. Vaccines (Basel). 2021 Nov 24;9(12):1388. doi: 10.3390/vaccines9121388. Vaccines (Basel). 2021. PMID: 34960134 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

17 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

17 results

Results by year